Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Éva Kenyeres

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Heliyon|January 27, 2025
Improvements of particle filter optimization algorithm for robust optimization under different types of uncertaintiesÉva Kenyeres, Alex Kummer, János Abonyi
Scientific Reports|March 26, 2026
Subtractive clustering for spatial resource allocation problems in waste managementÉva Kenyeres, Alex Kummer, János Abonyi
Entropy (Basel, Switzerland)|July 26, 2024
Machine Learning Classifier-Based Metrics Can Evaluate the Efficiency of Separation SystemsÉva Kenyeres, Alex Kummer, János Abonyi
International Journal of Molecular Sciences|September 26, 2020
Cardioprotective Effect of Novel Matrix Metalloproteinase InhibitorsKamilla Gömöri, Tamara Szabados, Éva Kenyeres, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
Identification of New, Translatable ProtectomiRs against Myocardial Ischemia/Reperfusion Injury and Oxidative Stress: The Role of MMP/Biglycan Signaling PathwaysTamara Szabados, Arnold Molnár, Éva Kenyeres, et al.
Frontiers in Pharmacology|April 6, 2019
Subantimicrobial Dose Doxycycline Worsens Chronic Arthritis-Induced Bone Microarchitectural Alterations in a Mouse Model: Role of Matrix Metalloproteinases?Ádám Horváth, Bálint Botz, Tamás Kiss, et al.
Cardiovascular Drugs and Therapy|January 5, 2021
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac MyocytesGerhild Euler, Fabian Locquet, Joanna Kociszewska, et al.
Frontiers in Pharmacology|April 21, 2018
Development of Matrix Metalloproteinase-2 Inhibitors for CardioprotectionPéter Bencsik, Krisztina Kupai, Anikó Görbe, et al.
Biochemical Pharmacology|June 17, 2020
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in ratsSzilvia B László, Bernadette Lázár, Gábor B Brenner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Heliyon|January 27, 2025
Improvements of particle filter optimization algorithm for robust optimization under different types of uncertaintiesÉva Kenyeres, Alex Kummer, János Abonyi
Scientific Reports|March 26, 2026
Subtractive clustering for spatial resource allocation problems in waste managementÉva Kenyeres, Alex Kummer, János Abonyi
Entropy (Basel, Switzerland)|July 26, 2024
Machine Learning Classifier-Based Metrics Can Evaluate the Efficiency of Separation SystemsÉva Kenyeres, Alex Kummer, János Abonyi
International Journal of Molecular Sciences|September 26, 2020
Cardioprotective Effect of Novel Matrix Metalloproteinase InhibitorsKamilla Gömöri, Tamara Szabados, Éva Kenyeres, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
Identification of New, Translatable ProtectomiRs against Myocardial Ischemia/Reperfusion Injury and Oxidative Stress: The Role of MMP/Biglycan Signaling PathwaysTamara Szabados, Arnold Molnár, Éva Kenyeres, et al.
Frontiers in Pharmacology|April 6, 2019
Subantimicrobial Dose Doxycycline Worsens Chronic Arthritis-Induced Bone Microarchitectural Alterations in a Mouse Model: Role of Matrix Metalloproteinases?Ádám Horváth, Bálint Botz, Tamás Kiss, et al.
Cardiovascular Drugs and Therapy|January 5, 2021
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac MyocytesGerhild Euler, Fabian Locquet, Joanna Kociszewska, et al.
Frontiers in Pharmacology|April 21, 2018
Development of Matrix Metalloproteinase-2 Inhibitors for CardioprotectionPéter Bencsik, Krisztina Kupai, Anikó Görbe, et al.
Biochemical Pharmacology|June 17, 2020
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in ratsSzilvia B László, Bernadette Lázár, Gábor B Brenner, et al.
Pageof 1